Synthetic biology startups are giving investors an appetite

There’s a growing wave of commercial activity from companies that are creating products using new biological engineering technologies. Perhaps the most public (and tastiest) example of the promise biomanufacturing holds is Impossible Foods . The meat replacement company whose ground plants (and bioengineered additives) taste like ground beef just raised another $200 million earlier this […]

We asked 12 Boston startups about their diversity efforts

TechCrunch ist Teil von Verizon Media. Klicken Sie auf ‘Ich stimme zu.‘, um Verizon Media und dessen Partnern Ihre Einwilligung zu geben, Cookies und ähnliche Technik zu nutzen, um auf Ihr Gerät zuzugreifen und Ihre Daten (einschließlich Standort) zu nutzen, um mehr über Ihre Interessen zu erfahren, personalisierte Anzeigen bereitzustellen und deren Effektivität zu messen. […]

Counting down Boston’s biggest venture rounds from 2019

TechCrunch ist jetzt Teil der Verizon Media-Familie. Wir (Verizon Media) und unsere Partner benötigen Ihre Einwilligung, um auf Ihr Gerät zuzugreifen, Cookies zu setzen und Ihre Daten einschließlich Ihres Standorts zu nutzen, um mehr über Ihre Interessen zu erfahren, relevante Werbung bereitzustellen und deren Effektivität zu messen. Verizon Media stellt Ihnen zudem relevante Anzeigen auf […]

Startups Weekly: Upfront Ventures bets on a bus service

Hello and welcome back to Startups Weekly, a weekend newsletter that dives into the week’s noteworthy news pertaining to startups and venture capital. Before I jump into today’s topic, let’s catch up a bit. Last week, I profiled an e-commerce startup Part & Parcel. Before that, I wrote about Stripe’s grand plans. Remember, you can […]

Boston gets a new biotech accelerator with the launch of Petri

As biotechnology becomes more central to new innovations in healthcare, material science and manufacturing, one of the nation’s research hubs is getting a new accelerator called Petri to launch companies focused on the commercialization of new technologies. Backed by the Boston-based venture capital firm Pillar, Petri has a three-year $15 million commitment to back companies […]

Biotech researchers venture into the wild to start their own business

Jorge Conde Contributor Jorge Conde is a General Partner at Andreessen Horowitz where he leads investments at the cross section of biology, computer science and engineering. Much of Silicon Valley mythology is centered on the founder-as-hero narrative. But historically, scientific founders leading the charge for bio companies have been far less common. Developing new drugs […]

Cannabis processing startups hope to unlock new chemicals and treatments

Jeff Ubersax knows yeast. The chief executive officer of Demetrix studied yeast genetics and biochemistry in school and was an early employee at Amyris Biotechnologies, a technology company that was using fermentation to make biofuels back in the early days of the first clean technology boom back in 2008.  Now, the same technology that Ubersax […]

From lab-grown meat to fermented fungus, here’s what corporate food VCs are serving up

Joanna Glasner Contributor More posts by this contributor A record $2.5B went to US insurance startup deals last year, and big insurers are in all the way Space tech rockets higher In a foodie’s ideal world, we’d all eat healthy, minimally processed cuisine sourced from artisanal farmers, bakers and chefs. In the real world, however, […]

Ginkgo Bioworks secures $275 million in Series D, valuing the company at over $1 billion

 Boston biotech startup Ginkgo Bioworks has announced the raise of $275 million in Series D funding to build out its Bioworks3 production facility. The funding comes from previous investors Viking Global, Y Combinator’s Continuity Fund, Cascade Investment, Bill Gates, as well as new investor, General Atlantic. The company previously raised over $154 million, bringing the total […]